Toxicities: grade 3 or greater nonhematologic toxicities regardless of attribution during cycles 1-2
| Infections/febrile neutropenia . | 11 patients . |
|---|---|
| Pneumonia | 4 |
| Cellulitis | 1 |
| Bloodstream | 2 |
| Neutropenic fever | 4 |
| Organ toxicities* | 23 events |
| Neurotoxicity | 3 |
| Gastrointestinal | 3 |
| Pulmonary | 3 |
| DVT/PE | 2 |
| Hyperglycemia | 6 |
| Confusion | 1 |
| Rash | 1 |
| Acute renal failure | 1 |
| Atrial fibrillation | 1 |
| Syncope | 2 |
| Death | 4 patients |
| Infection | 2 |
| Pulmonary fibrosis | 1 |
| Disease | 1 |
| Infections/febrile neutropenia . | 11 patients . |
|---|---|
| Pneumonia | 4 |
| Cellulitis | 1 |
| Bloodstream | 2 |
| Neutropenic fever | 4 |
| Organ toxicities* | 23 events |
| Neurotoxicity | 3 |
| Gastrointestinal | 3 |
| Pulmonary | 3 |
| DVT/PE | 2 |
| Hyperglycemia | 6 |
| Confusion | 1 |
| Rash | 1 |
| Acute renal failure | 1 |
| Atrial fibrillation | 1 |
| Syncope | 2 |
| Death | 4 patients |
| Infection | 2 |
| Pulmonary fibrosis | 1 |
| Disease | 1 |
DVT indicates deep-vein thrombosis; and PE, pulmonary embolism.
Toxicities that recurred in individual patients in both cycles 1 and 2 are listed as 2 events.